H. pylori prospective treatment for asymptomatic ulcer patients is cost-effective, study says.
Executive Summary
H. PYLORI ERADICATION FOR ASYMPTOMATIC DUODENAL ULCER PATIENTS who are controlled on maintenance therapy is recommended in a pharmacoeconomic study by Mark Fendrick, MD, et al. of the University of Michigan, presented May 14 at the Association for Pharmacoeconomics & Outcomes Research annual meeting in Philadelphia. "Based on the clinical and economic outcomes, patients with documented peptic ulcers not previously eradicated for H. pylori should be promptly identified and treated," Fendrick declared.